Literature DB >> 23959458

[Urological surgery with analogosedation and local anesthesia. What makes sense?].

S Tschirdewahn, H Rübben, M Schenck.   

Abstract

OBJECTIVE: Analogosedation and local anesthesia, including regional nerve blocks are used for endoscopic diagnostic or radiological and ultrasound-guided procedures in which the patient should not move or has to be free of pain. We retrospectively analyzed patient satisfaction, complications and the risk of urological interventions with analgosedation and/or local anesthesia between 2008 and 2012.
MATERIAL AND METHODS: In total 21,690 urological patients underwent surgical treatment at the Department of Urology of the University Hospital of Essen between 2008 and 2012 and 3,327 of these cases were performed by urologists with the patient under analogosedation (n=1484) and local anesthesia (n=1843). In total 13 surgical and endoscopic procedures were separately analyzed and evaluated for safety and practicability.
RESULTS: In five cases (0.15%) the procedures with analgosedation or local anesthesia were interrupted because of agitation (n=3) and in one case the transurethal resection was stopped due to a large bladder tumor. One patient suffered anaphylactic shock after preoperative intravenous application of cefuroxim 1.5 g. After cardiopulmonary resuscitation and a short stay on the intensive care unit the patient was discharged after 2 days.Conclusions. Local anesthesia and analgosedation should be performed by urologists for minor surgery, endoscopic procedures and radiological or ultrasound-guided treatment. For safety reasons there should always be a second medical doctor present for assistance. Analgesia with deep sedation or loss of defensive reflexes should be administered by anesthesiologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959458     DOI: 10.1007/s00120-013-3316-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  Practice guidelines for sedation and analgesia by non-anesthesiologists.

Authors: 
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

2.  Transurethral resection of prostate under sedation and local anesthesia (sedoanalgesia). Experience in 100 patients.

Authors:  B R Birch; J S Gelister; C J Parker; H Chave; R A Miller
Journal:  Urology       Date:  1991-08       Impact factor: 2.649

3.  Guidelines for sedation and/or analgesia by non-anaesthesiology doctors.

Authors:  J T A Knape; H Adriaensen; H van Aken; W P Blunnie; C Carlsson; M Dupont; T Pasch
Journal:  Eur J Anaesthesiol       Date:  2007-07       Impact factor: 4.330

4.  Transurethral resection of prostate with intravenous sedation.

Authors:  J R Lichtwardt; S Girgis
Journal:  Urology       Date:  1985-08       Impact factor: 2.649

5.  Does monitoring have an effect on patient safety? Monitoring instruments have significantly reduced anesthetic mishaps.

Authors:  E C Pierce
Journal:  J Clin Monit       Date:  1988-04

6.  Deaths associated with dentistry.

Authors:  M P Coplans; I Curson
Journal:  Br Dent J       Date:  1982-11-16       Impact factor: 1.626

7.  Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia?

Authors:  Marcus Schenck; Catarina Schenck; Herbert Rübben; Martin Stuschke; Tim Schneider; Andreas Eisenhardt; Roberto Rossi
Journal:  World J Urol       Date:  2012-11-16       Impact factor: 4.226

8.  Midazolam in combination with propofol for sedation during local anesthesia.

Authors:  E Taylor; A F Ghouri; P F White
Journal:  J Clin Anesth       Date:  1992 May-Jun       Impact factor: 9.452

9.  Patient-controlled sedation with propofol for colonoscopy.

Authors:  J M Ng; C F Kong; D Nyam
Journal:  Gastrointest Endosc       Date:  2001-07       Impact factor: 9.427

10.  [Pudendal block or combined spinal-epidural anaesthesia in high-dose-rate brachytherapy for prostate carcinoma?].

Authors:  M Schenck; S J Kliner; M Achilles; C Schenck; K Berkovic; H Ruebben; M Stuschke
Journal:  Aktuelle Urol       Date:  2009-11-30       Impact factor: 0.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.